Insight Molecular Diagnostics Inc. Earnings Per Share (Basic)
Insight Molecular Diagnostics Inc. (IMDX) reported Earnings Per Share (Basic) of -$0.31 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.31.
- Insight Molecular Diagnostics Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.12.
- Insight Molecular Diagnostics Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.72.
- Insight Molecular Diagnostics Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.34.
- Insight Molecular Diagnostics Inc. earnings per share, basic for fiscal 2025 was -$1.65.
- Insight Molecular Diagnostics Inc. earnings per share, basic for fiscal 2024 was -$4.66.
- Insight Molecular Diagnostics Inc. earnings per share, basic for fiscal 2023 was -$3.75.
- Insight Molecular Diagnostics Inc. earnings per share, basic for fiscal 2022 was -$13.25.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.31 10-Q · filed 2026-08-10 | -$0.44 10-Q · filed 2026-08-10 | ||||||
| 2026-03-31 | -$0.12 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$1.36 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.65 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | -$0.34 10-Q · filed 2025-11-10 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.91 10-Q · filed 2025-11-10 | -$2.27 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2025-06-30 | -$0.30 10-Q · filed 2026-08-10 | -$0.57 10-Q · filed 2026-08-10 | -$1.99 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$2.86 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2025-03-31 | -$0.26 10-Q · filed 2026-05-13 | -$1.86 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$2.83 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$3.34 derived: net income ÷ weighted average shares · filed 2026-05-13 | ||||
| 2024-12-31 | -$1.92 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$3.02 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$3.52 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$4.66 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | -$0.98 10-Q · filed 2025-11-10 | -$1.36 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$2.36 10-Q · filed 2025-11-10 | -$4.05 derived: net income ÷ weighted average shares · filed 2025-11-10 | ||||
| 2024-06-30 | -$0.36 10-Q · filed 2025-08-11 | -$1.32 10-Q · filed 2025-08-11 | -$3.07 derived: net income ÷ weighted average shares · filed 2025-08-11 | -$3.91 derived: net income ÷ weighted average shares · filed 2025-08-11 | ||||
| 2024-03-31 | -$1.13 10-Q · filed 2025-05-12 | -$3.09 derived: net income ÷ weighted average shares · filed 2025-05-12 | -$3.90 derived: net income ÷ weighted average shares · filed 2025-05-12 | -$4.97 derived: net income ÷ weighted average shares · filed 2025-05-12 | ||||
| 2023-12-31 | -$1.96 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$2.77 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$3.84 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$3.75 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | -$0.81 10-Q · filed 2024-11-12 | -$1.88 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.68 10-Q · filed 2024-11-12 | -$5.45 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||||
| 2023-06-30 | -$1.07 10-Q · filed 2024-08-08 | -$0.83 10-Q · filed 2024-08-08 | -$4.46 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$7.01 derived: net income ÷ weighted average shares · filed 2024-08-08 | ||||
| 2023-03-31 | $0.40 10-Q · filed 2024-05-15 | $0.02 10-Q · filed 2023-05-15 | -$3.22 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$5.85 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$8.99 derived: net income ÷ weighted average shares · filed 2024-05-15 | |||
| 2022-12-31 | -$2.04 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$4.95 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$8.56 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$13.25 10-K · filed 2024-04-16 | -$0.66 10-K · filed 2023-04-12 | |||
| 2022-09-30 | -$1.62 10-Q · filed 2023-11-09 | -$0.08 10-Q · filed 2022-11-10 | -$3107.83 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$5.22 10-Q · filed 2023-11-09 | -$0.26 10-Q · filed 2022-11-10 | $1.50 derived: net income ÷ weighted average shares · filed 2023-11-09 | ||
| 2022-06-30 | -$1.48 10-Q · filed 2023-08-10 | -$0.07 10-Q · filed 2022-08-12 | -$3.63 10-Q · filed 2023-08-10 | -$0.18 10-Q · filed 2022-08-12 | $0.96 derived: net income ÷ weighted average shares · filed 2023-08-10 | $3.44 derived: net income ÷ weighted average shares · filed 2023-08-10 | ||
| 2022-03-31 | -$0.11 10-Q · filed 2023-05-15 | $0.54 derived: net income ÷ weighted average shares · filed 2023-05-15 | $2.27 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$27.17 derived: net income ÷ weighted average shares · filed 2023-05-15 | ||||
| 2021-12-31 | $0.14 derived: net income ÷ weighted average shares · filed 2023-04-12 | $0.58 derived: net income ÷ weighted average shares · filed 2023-04-12 | $2.21 derived: net income ÷ weighted average shares · filed 2023-04-12 | -$0.72 10-K · filed 2023-04-12 | ||||
| 2021-09-30 | -$0.15 10-Q · filed 2022-11-10 | -$0.27 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.32 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$0.12 10-Q · filed 2022-08-12 | -$0.17 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | -$0.05 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |